David A. Gordon, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 1447 York Rd Ste 406, Lutherville, MD 21093 Phone: 410-343-3001 Fax: 410-823-0015 |
Dr. Michael Wayne Brown, MD Urology Medicare: Not Enrolled in Medicare Practice Location: 1447 York Rd Ste 406, Lutherville, MD 21093 Phone: 410-343-3001 Fax: 410-823-0015 |
Chirag Yashvantkumar Patel, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 1447 York Rd Ste 100, Kaiser Permanente Towson Medical Center, Lutherville, MD 21093 Phone: 410-339-5500 |
News Archive
Omthera Pharmaceuticals, Inc., a privately-held emerging specialty pharmaceuticals company, announced today that the first patient has been enrolled in its ESPRIT Phase III clinical trial of Epanova, in patients with hypertriglyceridemia (TG level greater than or equal to 200 and < 500 mg/dL) despite treatment with a statin.
In the first study of vitamin K and Non-Hodgkin lymphoma risk, researchers at the Mayo Clinic campus in Minnesota have found that people who have higher intakes of vitamin K from their diet have a lower risk of developing Non-Hodgkin lymphoma.
Bioponic Phytoceuticals has announced that its Curecumin (a Bioresonant Phytotherapeutic form of Turmeric containing curcumin in a liquid nasal delivery system) may be an important treatment for Lung Cancer.
For patients with Huntington's disease (HD), clinical trials can offer hope when there are no treatments available despite unknowns about whether the therapy will work or is safe.
Including a coronary artery calcium score in a risk assessment for future heart disease events, such as heart attacks, provides a better estimate in some populations than a standard coronary risk factors assessment, according to research supported by the National Heart, Lung, and Blood Institute (NHLBI), part of the National Institutes of Health.
› Verified 8 days ago